Inactivated vaccine immunopotentiator for poultry as well as preparation method and application of inactivated vaccine immunopotentiator
By using immune enhancers of quercetin, rutin and astragalus polysaccharides in inactivated vaccines for poultry, the problems of unsatisfactory immunity and decreased immunity of poultry vaccines were solved, significantly improving antibody response and immune protection, and prolonging the The protection period of the vaccine and alleviates adverse reactions after vaccination.
Patent Information
- Application Number
- CN202411028767.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-08
AI Technical Summary
In poultry farming, the immunity of vaccines may not be ideal, especially under stress conditions, which will weaken, affecting the effectiveness of vaccines, and poultry faces the threat of major infectious diseases such as avian influenza.
Using an inactivated vaccine immunization enhancer for avian use, including quercetin, rutin and astragalus polysaccharides, the combination of these ingredients is combined with the mass fraction of quercetin 40%, rutin 40% and 20% rutin polysaccharides. Antioxidant, anti-inflammatory and immune regulation effects significantly improve the quality and stability of immune response after vaccination.
Significantly improves the antibody response and cellular immune response, prolongs the protection period of vaccines, reduces the need for frequent vaccination, and reduces adverse reactions after vaccination, such as excessive inflammatory response, improves the overall health level of poultry, and in the face of the Maintain a stable immune state during stimulation.
Smart Images

Figure BDA0004969333680000091
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological products, and more specifically, to an inactivated vaccine immunopotentiator for poultry, a preparation method thereof and an application thereof. Background Art
[0002] The development background of inactivated vaccine immunopotentiators for poultry is to solve the challenges faced in poultry farming, especially in the process of poultry vaccination. With the development of poultry farming, major infectious diseases such as avian influenza and Newcastle disease (ND) pose a serious threat to poultry health and the stable development of the farming industry. In order to prevent the outbreak and spread of these infectious diseases, vaccination is usually used to improve the immunity of poultry to specific pathogens. However, vaccination is not foolproof. The immune effect of some vaccines may not be ideal, or the immune protection of the vaccine may be weakened under certain stress conditions. In addition, poultry may experience stress factors such as transportation and changes in the breeding environment during the breeding process. These factors may affect the body's immune status, leading to a decrease in immunity, thereby affecting the efficacy of the vaccine.
[0003] To address the above issues, researchers have begun to explore ways to enhance the immune effects of vaccines, one of which is the development of immunopotentiators. The purpose of immunopotentiators is to improve the effectiveness of vaccines by stimulating or enhancing the body's immune response, thereby increasing poultry's resistance to pathogens. Immunopotentiators can work in a variety of ways, such as activating the complement system, promoting antibody production, and enhancing cellular immunity. The use of immunopotentiators in poultry vaccination can help ensure vaccine effectiveness and increase poultry's response to vaccination, thereby more effectively preventing the occurrence of infectious diseases.
[0004] Therefore, the present invention aims to provide an inactivated vaccine immunopotentiator for poultry, which has significant comprehensive effects in supporting the immune system, alleviating inflammation and anti-oxidation. Summary of the invention
[0005] The purpose of the present invention is to provide an inactivated vaccine immunopotentiator for poultry, which has remarkable comprehensive effects in supporting the immune system, alleviating inflammation and resisting oxidation.
[0006] The above technical purpose of the present invention is achieved through the following technical scheme: an inactivated vaccine immunopotentiator for poultry, the immunopotentiator comprising quercetin, rutin and astragalus polysaccharide, the mass fractions of the components of the immunopotentiator being as follows: 30-50% quercetin, 30-50% rutin and 10-30% astragalus polysaccharide.
[0007] The present invention is further configured as follows: the mass fractions of the components of the immunopotentiator are as follows: 40% quercetin, 40% rutin and 20% astragalus polysaccharide.
[0008] By adopting the above technical scheme, the combination of quercetin, rutin and astragalus polysaccharide of the present invention can complement and enhance each other, exert a synergistic effect, comprehensively enhance the immune enhancement effect, and the comprehensive play of antioxidant, anti-inflammatory and immunomodulatory effects can significantly improve the quality and stability of the immune response after vaccination; based on experimental and application experience, the mass fractions of quercetin, rutin and astragalus polysaccharide of the present invention are set to 40% quercetin, 40% rutin and 20% astragalus polysaccharide. This ratio can maximize the advantages of the three ingredients and achieve the best immune enhancement effect.
[0009] Another object of the present invention is to provide an avian influenza H5 inactivated vaccine comprising the above-mentioned immunopotentiator and avian influenza H5 antigen.
[0010] The present invention is further configured as follows: the mass ratio of the immunopotentiator to the avian influenza H5 antigen is 45-55, 45-55.
[0011] By adopting the above technical scheme, the present invention can significantly improve the antibody response and cellular immune response of the avian influenza H5 inactivated vaccine by adding an immunopotentiator, and enhance the body's immune protection against the virus. This combination can improve the antibody titer after vaccination, enhance the production of neutralizing antibodies, and improve resistance to the avian influenza H5 virus; the use of immunopotentiators can extend the protection period of the vaccine, so that poultry can maintain a high level of immunity for a long time after vaccination, reduce the need for frequent vaccination, and by optimizing the immune response, the immunopotentiator can reduce adverse reactions after vaccination, such as excessive inflammatory reactions, etc., and improve the overall health level of poultry. In the process of poultry breeding, when faced with stress factors such as transportation and environmental changes, the immunopotentiator can help maintain a stable immune state and ensure that the efficacy of the vaccine is not affected. .
[0012] Another object of the present invention is to provide an application of the above-mentioned poultry inactivated vaccine immunopotentiator, which is used as an immunopotentiator for avian influenza H5 vaccine.
[0013] Another object of the present invention is to provide a method for preparing an inactivated vaccine immunopotentiator for poultry, comprising the following steps:
[0014] S1: adding dimethyl sulfoxide to quercetin and stirring at room temperature until the quercetin is completely dissolved to form a uniform quercetin solution;
[0015] S2: Add rutin to dimethyl sulfoxide and stir at room temperature until the rutin is completely dissolved to form a uniform rutin solution;
[0016] S3: Add an appropriate amount of astragalus polysaccharide to sterile water and stir at room temperature until the astragalus polysaccharide is completely dissolved to form a uniform astragalus polysaccharide solution;
[0017] S4: Take the dissolved quercetin solution, rutin solution, and astragalus polysaccharide solution, put the weighed solutions into the same container, and stir them fully at room temperature to completely mix the three to form a uniform combined formula solution.
[0018] The present invention is further configured as follows: the ratio of the quercetin and rutin to the dimethyl sulfoxide is 1:10.
[0019] By adopting the above technical scheme, the poultry inactivated vaccine immunopotentiator prepared by this method has the advantages of high dissolution efficiency, good uniformity, simple preparation process, reasonable ratio and good stability. This method not only improves the preparation efficiency and product quality, but also facilitates large-scale production and application promotion, ensuring that the immune effect of the vaccine can be significantly enhanced in practical applications, providing a stronger guarantee for disease prevention and control.
[0020] In summary, the present invention has the following beneficial effects:
[0021] 1. The present invention adopts a combination of quercetin, rutin and astragalus polysaccharide, and through the comprehensive effects of anti-oxidation, anti-inflammatory and immunomodulation, significantly improves the quality and stability of the immune response after vaccination, and the mass fractions of quercetin, rutin and astragalus polysaccharide are set to 40% quercetin, 40% rutin and 20% astragalus polysaccharide. This ratio can maximize the advantages of the three ingredients and achieve the best immune enhancement effect;
[0022] 2. The inactivated avian influenza H5 vaccine added with the immunopotentiator in the present invention significantly improves the antibody titer and the production of neutralizing antibodies, and enhances the resistance to the avian influenza H5 virus. The use of the present invention prolongs the protection period of the vaccine, so that poultry can maintain a high level of immunity for a long time after vaccination, reducing the need for frequent vaccination. By optimizing the immune response, the immunopotentiator can reduce adverse reactions after vaccination, such as excessive inflammatory response, and improve the overall health level of poultry. DETAILED DESCRIPTION
[0023] The present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. In the description of the present invention, it should be noted that, if no specific conditions are specified in the embodiments, the conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0024] Example 1: An inactivated vaccine immunopotentiator for poultry, comprising quercetin, rutin and astragalus polysaccharide, wherein the mass fractions of the components of the immunopotentiator are as follows: 40% quercetin, 40% rutin and 40% astragalus polysaccharide.
[0025] The preparation method of the above-mentioned poultry inactivated vaccine immunopotentiator comprises the following steps:
[0026] S1: Take a certain amount of quercetin, add dimethyl sulfoxide in a ratio of 1:10, and stir at room temperature until the quercetin is completely dissolved to form a uniform quercetin solution;
[0027] S2: Take a certain amount of rutin, add dimethyl sulfoxide in a ratio of 1:10, and stir at room temperature until the rutin is completely dissolved to form a uniform rutin solution;
[0028] S3: Add an appropriate amount of astragalus polysaccharide to sterile water and stir at room temperature until the astragalus polysaccharide is completely dissolved to form a uniform astragalus polysaccharide solution;
[0029] S4: Take the dissolved quercetin solution, rutin solution, and astragalus polysaccharide solution, put the weighed solutions into the same container, and stir them fully at room temperature to completely mix the three to form a uniform combined formula solution.
[0030] Working principle: Quercetin in the present invention is a natural flavonoid compound with powerful antioxidant, anti-inflammatory and immunomodulatory effects. Quercetin can protect immune cells and improve their functions by removing free radicals and reducing the damage of oxidative stress to cells. Quercetin can inhibit the release of inflammatory mediators, reduce excessive inflammatory reactions in immune responses, and help maintain the balance of the immune system. Quercetin can activate immune cells, such as macrophages, T cells, etc., enhance humoral immunity and cellular immune responses, and improve the body's resistance to pathogens.
[0031] Rutin in the present invention is also a flavonoid compound, which has antioxidant, anti-inflammatory and vascular protective effects. Similar to quercetin, rutin protects cells from oxidative damage by scavenging free radicals. Rutin can inhibit inflammatory reactions and reduce the production of inflammatory mediators, which helps to reduce local and systemic inflammatory reactions after vaccination. Rutin regulates the function of immune cells, promotes antibody production and cell-mediated immune response, and enhances the immune effect of vaccines.
[0032] Astragalus polysaccharide in the present invention is a type of polysaccharide extracted from Astragalus, which has immunomodulatory, antiviral and antioxidant effects. Astragalus polysaccharide can significantly improve the phagocytic ability of macrophages, enhance the function of T cells and B cells, and promote the production of cytokines. Astragalus polysaccharide can enhance the body's antioxidant defense system and reduce the damage of oxidative stress to immune cells.
[0033] The present invention enhances antibody response, cellular immune response and immune memory. The immunopotentiator can significantly improve the immune effect of the vaccine, ensure that the poultry can effectively resist the infection of pathogens after vaccination, prolong the immune persistence, enable the poultry to maintain a high immunity for a long time, and reduce the frequency of vaccination. By optimizing the immune response, the immunopotentiator can reduce adverse reactions after vaccination, improve the health level of poultry, reduce excessive inflammatory response, and alleviate stress and discomfort after vaccination. In the process of poultry breeding, in the face of various stress factors, the immunopotentiator can help maintain a stable immune state and ensure that the vaccine efficacy is not affected. The immunopotentiator is suitable for a variety of inactivated vaccines for poultry, has broad application prospects, and can be promoted to different types of poultry breeding.
[0034] Example 2: Immunoenhancement effect of poultry inactivated vaccine immunopotentiator on avian influenza H5 inactivated vaccine
[0035] 1. Security of the combination
[0036] Experimental subjects: 10 healthy chickens were selected in each group for the experiment.
[0037] Injection plan: Each group of chickens is injected with immune enhancers containing different formulations. After the injection, the chickens are observed every day and their mental state and feeding habits are recorded.
[0038] Mental state: The mental state of the chickens was evaluated by observing indicators such as their activity level, feather gloss, and reaction agility. The chickens were active during the trial, had no abnormal behavior, had good feather gloss, and were quick to react.
[0039] Feeding situation: record the daily feed intake and feeding enthusiasm of the chickens; during the experiment, the chickens ate normally, without anorexia or refusal to eat, and had a high feeding enthusiasm.
[0040] Experimental Results
[0041] Within 15 days: No deaths occurred in all chickens injected with immune enhancers.
[0042] Mental state: The chickens were in good spirits and active throughout the experiment, without any abnormal behavior or mental depression.
[0043] Feeding situation: The feeding situation of the chickens remained normal, with no significant difference in daily feed intake compared with before injection, and the chickens were highly motivated to eat.
[0044] Conclusion: The experimental results show that the immunopotentiator composed of quercetin, rutin and astragalus polysaccharide is safe for chickens at the selected dose, with no toxic side effects. The chickens had no adverse reactions after injection of the immunopotentiator, and their mental state and feeding conditions were good, which further verified the applicability of the immunopotentiator. Through observation of the chickens, the immunopotentiator had no negative impact on the normal life of the chickens, indicating that flavonoids as immunopotentiators are not only safe and reliable, but also can provide effective immunopotentiating effects without affecting the daily behavior of the chickens.
[0045] 2. Experimental design
[0046] Experimental subjects and sources: 150 SPF chicks from Zhaoqing Dahuanong Biopharmaceutical Co., Ltd.
[0047] Grouping: 150 SPF chicks were randomly divided into five groups: A, B, C, D, and E, with 10 chicks in each group, and repeated for a total of 3 groups to ensure balanced grouping.
[0048] Group A: Control group (no immune enhancer)
[0049] Group B: Experimental group (using immune enhancer combination B)
[0050] Group C: Experimental group (using immune enhancer combination C)
[0051] Group D: Experimental group (using immune enhancer combination D)
[0052] Group E: Experimental group (using immune enhancer combination E)
[0053] Trial period: 28 days
[0054] Immunization schedule: Blood samples were collected one day before the test and on the 7th, 14th, 21st and 28th days after immunization.
[0055] Preparation before the experiment: Ensure that the chicken house has good sanitary conditions, appropriate temperature and humidity, and provide sufficient feed and drinking water. Before the experiment begins, conduct a health check on 150 SPF chicks to ensure that there is no disease infection.
[0056] Blood collection steps: Each time blood was collected, 9 chickens were randomly selected from each group, and the wing vein blood collection method was used to ensure standardized operation and reduce stress reactions on the chickens. The collected blood was centrifuged and serum was extracted;
[0057] Antibody level detection: The hemagglutination test (HA) was used to detect the red blood cell agglutination reaction, and the hemagglutination inhibition test (HI) was used to detect the neutralizing ability of antibodies in the serum. The results were expressed in log2 form, and the average value was calculated.
[0058] Data recording and analysis: The antibody level results of each blood test were recorded in detail. The antibody levels of different groups at different time points were compared and analyzed using statistical analysis software. The changes in antibody levels were displayed in charts to evaluate the effects of different immune enhancer combinations on the immune response of SPF chicks. The antibody enhancement effects of each combination after pathogen immunization are shown in Table 2 below.
[0059] Table 1 Experimental groups
[0060] Group White oil Immunostimulants formula antigen A(Control) Esso none antigen Re13 B Esso B Antigen + B Re13 C Esso C Antigen+C Re13 D Esso D Antigen+D Re13 E Esso E Antigen+E Re13
[0061] Table 2 Antibody enhancement after pathogen immunization
[0062]
[0063] Experimental results: The antibody levels of chicks in each group were tested one day before immunization and on the 7th, 14th, 21st and 28th days after immunization. The test results showed that the antibody levels of each test group were significantly higher than that of the control group at any time after immunization.
[0064] The present invention analyzes the antibody level of each group by statistical method, and the results show that the antibody level of each test group at different time points is significantly different from that of the control group (p < 0.05). This significant difference indicates that the immunopotentiator has a significant effect on improving the immune antibody level of chicks.
[0065] The above results show that the immunopotentiator composed of quercetin, rutin and astragalus polysaccharide can significantly improve the immune antibody level of SPF chicks. The immunopotentiator enhances the chicks' resistance to disease by increasing the antibody level. During the experiment, the chicks in the test group had no adverse reactions, and their mental state and feeding conditions were good, which further verified the safety of the immunopotentiator. The antibody levels of each test group increased significantly after immunization, indicating that the immunopotentiator has good applicability in practical applications.
[0066] In summary, the antibody levels of each test group of the present invention were significantly higher than those of the control group at each time point after immunization (p < 0.05), which proves that the immunopotentiator has a significant effect on improving the immune antibody level of chicks. During the experiment, the chicks performed normally without adverse reactions, indicating that the immunopotentiator has good safety and applicability while improving the immune antibody level. Although all immunopotentiator combinations are effective, there are differences in specific effects, which provides a reference for further optimizing the immunopotentiator combination.
[0067] This specific embodiment is merely an explanation of the present invention and is not a limitation of the present invention. After reading this specification, those skilled in the art may make non-creative modifications to the present embodiment as needed. However, as long as they are within the scope of the claims of the present invention, they are protected by the patent law.
Claims
1. An inactivated vaccine immunopotentiator for poultry, characterized in that: The immunopotentiator comprises quercetin, rutin and astragalus polysaccharide, and the mass fractions of the components of the immunopotentiator are as follows: 30-50% of quercetin, 30-50% of rutin and 10-30% of astragalus polysaccharide.
2. The poultry inactivated vaccine immunopotentiator according to claim 1, characterized in that: The mass fractions of the components of the immunopotentiator are as follows: 40% of quercetin, 40% of rutin and 20% of astragalus polysaccharide.
3. An avian influenza H5 inactivated vaccine, characterized in that: The invention comprises the immunopotentiator according to any one of claims 1 to 3 and an avian influenza H5 antigen.
4. An avian influenza H5 inactivated vaccine according to claim 4, characterized in that: The mass ratio of the immunopotentiator to the avian influenza H5 antigen is 45-55, 45-55.
5. An application of the poultry inactivated vaccine immunopotentiator according to any one of claims 1 to 3, characterized in that: Used as an immune enhancer for avian influenza H5 vaccine.
6. A method for preparing an inactivated vaccine immunopotentiator for poultry, characterized in that: The following steps are involved: S1: adding dimethyl sulfoxide to quercetin and stirring at room temperature until the quercetin is completely dissolved to form a uniform quercetin solution; S2: Add rutin to dimethyl sulfoxide and stir at room temperature until the rutin is completely dissolved to form a uniform rutin solution; S3: Add an appropriate amount of astragalus polysaccharide to sterile water and stir at room temperature until the astragalus polysaccharide is completely dissolved to form a uniform astragalus polysaccharide solution; S4: Take the dissolved quercetin solution, rutin solution, and astragalus polysaccharide solution, put the weighed solutions into the same container, and stir them fully at room temperature to completely mix the three to form a uniform combined formula solution.
7. The method for preparing an inactivated vaccine immunopotentiator for poultry according to claim 6, characterized in that: The ratio of the quercetin and rutin to the dimethyl sulfoxide is 1:10.
